Background: Idiopathic portal hypertension (IPH), the socalled Banti’s syndrome, is a condition clinically characterized by splenomegaly, hypersplenism, and increased portal pressure. IPH is uncommon in the Western world. In this article we report on a well-documented case of this rare form of disorder. Case Report: A 27-year-old woman was referred to our hospital with symptoms of severe pancytopenia,massive splenomegaly, and moderate esophageal varices with red color signs despite endoscopic variceal ligation. Upon admission, the hepatic functional reserve was satisfactory (Child-Pugh class A). The color-Doppler ultrasound showed an anatomically normal and non-thrombotic splenoportal venous axis. A complete gastroesophageal devascularization with splenectomy (Hassab-Paquet procedure)was performed. Intraoperatively the liver looked grossly normal while the microscopic examination revealed an inflammatory cell infiltration and fibrosis of the portal tract but no signs of liver cirrhosis. The final diagnosis of IPH was made based on the definitions adopted by the Japan IPH Study Committee. The patient has been asymptomatic for 12 months postoperatively, and hematological indices reached their normal values. The esophageal varices were eradicated. Conclusion: The literature on treatment strategies of esophageal varices due to IPH was reviewed with particular reference to the role of devascularization procedures and splenectomy in the management of this rare condition.

This content is only available via PDF.
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.